人类测量和基于CT的肥胖指数与亚临床动脉样硬化症的关联
Yosuke Higo1, Takashi Hisamatsu2,3, Yoshihisa Nakagawa1
1Department of Cardiovascular Medicine, Shiga University of Medical Science.
Journal of atherosclerosis and thrombosis
|August 9, 2023
概括
在男性中,肥胖指数与冠状动脉化 (CAC) 和大动脉化 (AoAC) 有着不同的关联. 没有与大动脉膜化 (AVC) 相关的指数.
科学领域:
- 心血管疾病研究研究
- 肥胖医学 肥胖医学
- 医学成像分析 医学成像分析
背景情况:
- 亚临床动脉样硬化,包括冠状动脉结石化 (CAC),大动脉结石化 (AoAC) 和大动脉结石化 (AVC),是一个重大的健康问题.
- 各种肥胖指数与这些不同的化类型之间的关联的比较强度仍然不完全理解.
研究的目的:
- 为了比较基于人体测量和计算机断层扫描 (CT) 的肥胖指数与CAC,AoAC和AVC在基于人口的男性队列之间的关联的强度.
- 调查不同肥胖程度如何与亚临床动脉样硬化的具体表现有关.
主要方法:
- 在931名男性 (平均年龄63.7岁) 的横截面分析中,使用人体测量指标 (BMI,腰围等) 进行测量. 和CT衍生的脂肪组织指数 (VAT,SAT,VSR,VTR).
- 使用CT扫描中的Agatston分数来量化CAC,AoAC和AVC.
- 多变量回归模型根据年龄,生活方式因素和CT扫描仪类型进行调整.
主要成果:
- 在CAC和AoAC中占比较高 (分别为62.6%和82.6%).
- 人类测量和基于CT的肥胖指数都与CAC积极相关 (p<0.01).
- 内脏与皮下脂肪组织比率 (VSR) 和内脏与总脂肪组织比率 (VTR) 与AoAC积极相关 (p<0.01),但没有肥胖指数与AVC相关.
结论:
- 肥胖指数和亚临床动脉样硬化之间的关联因具体的解剖位置和化的类型而异.
- 内脏脂肪的测量特别与男人的大动脉化有关.
相关概念视频
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
39
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
39
Coronary Artery Disease I: Introduction
20
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
13
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13
Imaging Studies for Cardiovascular System V: CT
42
Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
42
Obesity
534
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
534
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12


